Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
USP
USP
Activities:
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme
AI-driven approach promises a new class of depression treatment
IMA Ilapak Doytronic 120 wins Oscar de l’Emballage 2024 award
Innovative stand-up pouch machine recognised for primary packaging excellence
You need to be a subscriber to read this article.
Click here
to find out more.
Creating a framework to measure the impact of drug delivery devices
Alex Fong, Insights and Sustainability Lead at Owen Mumford, discusses the company’s lifecycle assessment (LCA) journey
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Ingredients
ATCC and USP launch product range to reduce risk in vaccine development
ATCC and USP have launched the first set of products from their collaboration to advance quality and reduce risk in the development of biological therapeutics and vaccines
Regulatory
USP launches programme to speed COVID-19 treatments
US Pharmacopeia has launched the Trust Accelerated programme to expand access to free USP technical expertise and resources to support regulatory predictability
Regulatory
USP publishes new and revised sterile compounding standards
Standards help ensure quality compounded preparations to safeguard the well-being of patients and those handling the compounds
Subscribe now